Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2025Dermatology and TherapyOpen Access

The ChinaSTAD Chinese Registry in Patients with Moderate-To-Severe Atopic Dermatitis Not Controlled by Topical Therapy: Baseline Characteristics, Disease Burden and Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

PLPing LiuBLBingjiang LinYSYanna Shen

Discussion

Loading...

Member takes

Overview

National prospective registry characterizes disease burden and treatment in moderate-to-severe atopic dermatitis patients, highlighting significant healthcare challenges.

Key Points

  • Patients with moderate-to-severe atopic dermatitis have high disease burden, with an average SCORAD of 54.4, indicating poor control.
  • Out of 2550 analyzed patients, 85.6% were classified as having uncontrolled atopic dermatitis based on ADCT scores.
  • The observational registry involved clinical and economic evaluations of patients aged 12 and older, assessing treatment and healthcare use.
  • These findings illustrate the substantial treatment needs and disease burden faced by patients in China, calling for improved management strategies.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/68d46fcd31b076d99fa69fd0https://doi.org/10.1007/s13555-025-01540-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Multicenter Cross-Sectional Study on Clinical Characteristics and Disease Burden of 1010 Patients with Moderate to Severe Atopic Dermatitis in Chinese Tertiary Hospitals2026
  2. 2Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia–Pacific Region: A Cross-sectional Survey2024 · 4 citations
  3. 3Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study2024 · 12 citations
  4. 4Associations of demographics, aggravating factors, comorbidities, and treatments with atopic dermatitis severity in China: A national cross-sectional study2024 · 3 citations
  5. 5Inadequate Disease Control with Current Therapies Among Patients with a History of Moderate-to-Severe Atopic Dermatitis2026